Home › Products › Oncology › Doxorex PL 2mg Injection
Doxorex PL 2mg Injection
Salt Composition: LIPOSOMAL DOXORUBICIN
- Manufacturer: SAMARTH LIFE SCIENCES PVT LTD
- Pack Size: 1 VIAL(s)
- Dosage Form: INJECTION
- Strength: 2MG
- Prescription Required
- Cold Chain
- Prepaid Only. Non-Returnable.
- Storage: Keep Doxorex PL 2mg Injection out of sight and reach of children. Store refrigerated at 2°C - 8°C. Do not freeze. Protect the medicine from light and excessive moisture. Keep the medicine out of reach of children and pets If you forgot to take the injection, inform your healthcare professional immediately and reschedule the appointment.
₹2185.00₹4750.00
Inclusive of all taxes
Product Introduction
Doxorex PL 2mg Injection is an anticancer medication containing doxorubicin encapsulated within liposomes (lipid spheres). Cancer is characterised by uncontrolled and abnormal cell multiplication. This medication is indicated for breast cancer, ovarian cancer, multiple myeloma (cancer of plasma cells, a type of white blood cell), and AIDS-related Kaposi's sarcoma. Patients with HIV infection carry the highest risk of developing Kaposi's sarcoma, a cancer arising in the lining of lymph vessels and blood vessels. Doxorex PL 2mg Injection may be administered as monotherapy or in combination with other anticancer medicines. This medication is not recommended for adolescents and children. Patients should use effective contraception during treatment and for at least six months following the final dose. It is important to inform your doctor of allergies to peanuts or soya, current use of medicines for heart or liver disorders, history of diabetes, Kaposi's sarcoma, or oral complications before commencing Doxorex PL 2mg Injection.
Uses
Doxorex PL 2mg Injection is used in the treatment of the following: Breast cancer Ovarian cancer Multiple myeloma AIDS-related Kaposiâs sarcoma
How it works
Doxorex PL 2mg Injection inhibits the enzyme topoisomerase II activity, which is involved in the DNA (genetic material) multiplication of cancer cells. This prevents the growth and multiplication of cancer cells. The unique formulation process of Doxorex PL 2mg Injection increases the time this medicine is circulating in the blood. It also helps deliver drugs from blood to the cancerous tissue rather than the healthy tissue.
How to Use
A health care professional will give it to you. Your physician will decide your dose and frequency of administration based on your disease condition and other factors. Do not self-administer.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. Serious side effects of Doxorex PL 2mg Injection are: Fever, tiredness, bruising or bleeding Severe diarrhoea, sores in the mouth, nausea, vomiting Lung infections, shortness of breath Severe stomach pain Severe weakness Common side effects of Doxorex PL 2mg Injection are: Low blood cell counts Hair loss Decreased appetite Skin rashes Pain in the muscles and joints Constipation Feeling confused, difficulty sleeping Headache, dizziness, sleepiness Change in taste High or low blood pressure Excessive sweating Pain when passing urine Weight loss Muscle spasms Fast heartbeat
Expert Tips
Inform the doctor if the patient has allergic reactions, diabetes, blood pressure, kidney, liver diseases before taking this medication. Blood glucose levels, blood pressure, and liver and kidney function should be monitored regularly while taking this medication. Don't stop this medication without the proper advice of the doctor. Avoid making plans for pregnancy or during pregnancy, as this medication can cause harmful effects on the developing baby. Avoid driving after taking this medication because it causes dizziness and lack of concentration.
References
- 1. Goodman & Gilmanâs, The Pharmacological Basis of Therapeutics, Cytotoxic agents, 12th edition, 2011, 1714. 2. KD Tripathi, Essentials of Medical Pharmacology, Anticancer drugs, 7th edition, 2013, 867. 3. Baxter Holding BV, European medicines agency (ema), [Revised on May 2006] [ Accessed on 4th Dec 2021], https://www.ema.europa.eu/en/documents/product-information/caelyx-pegylated-liposomal-epar-product-information_en.pdf 4. Ben Venue Laboratories, Inc, US Food and Drug Administration, [Revised on May 2007] [ Accessed on 4th Dec 2021], https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/050718s029lbl.pdf
Safety Advice
Pregnancy: unsafe Doxorex PL 2mg Injection may harm the unborn baby. You must tell your physician if you are pregnant or planning to get pregnant before taking this medicine.
Lungs: Consult your doctor It is unknown whether Doxorex PL 2mg Injection can be given to patients with lung diseases. Please consult your physician if you have any lung problems.
Breastfeeding: unsafe Stop breastfeeding before starting treatment with Doxorex PL 2mg Injection. You must tell your physician if you are breastfeeding before taking this medicine.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.